These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26938814)

  • 21. Do thiazide diuretics reduce central systolic blood pressure in hypertension?
    Yugar LBT; Moreno B; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    J Clin Hypertens (Greenwich); 2018 Jan; 20(1):133-135. PubMed ID: 29106774
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
    Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS
    Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial.
    Moes AD; Hesselink DA; van den Meiracker AH; Zietse R; Hoorn EJ
    Am J Kidney Dis; 2017 Jun; 69(6):796-804. PubMed ID: 28259499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
    Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of losartan and chlorthalidone on blood pressure and renal vascular resistance index in non-diabetic patients with essential hypertension and normal renal function.
    Caruso D; D'Avino M; Acampora C; Romano L; Bevilacqua N; Caruso G; Esposti DD; Borghi C
    J Cardiovasc Pharmacol; 2004 Nov; 44(5):520-4. PubMed ID: 15505487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive efficacy and tolerability of different drug regimens in isolated systolic hypertension in the elderly.
    Avanzini F; Alli C; Bettelli G; Corso R; Colombo F; Mariotti G; Radice M; Torri V; Tognoni G
    Eur Heart J; 1994 Feb; 15(2):206-12. PubMed ID: 8005121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension.
    Tziomalos K; Athyros VG; Mikhailidis DP; Karagiannis A
    Curr Pharm Des; 2013; 19(21):3766-72. PubMed ID: 23286433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial.
    Gnanenthiran SR; Wang N; Di Tanna GL; Salam A; Webster R; de Silva HA; Guggilla R; Jan S; Maulik PK; Naik N; Selak V; Thom S; Prabhakaran D; Schutte AE; Patel A; Rodgers A;
    JAMA Cardiol; 2022 Jun; 7(6):645-650. PubMed ID: 35416909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension.
    Sung KC; Hong SJ; Rhee MY; Jeong MH; Kim DH; Lim SW; Park K; Lee JB; Kim SY; Cho JM; Cho GY; Heo JH; Kim SH; Lee HY; Kim W; Cho DK; Park S; Shin J; Pyun WB; Kwon K; Rha SW; Jung JA
    J Clin Hypertens (Greenwich); 2023 May; 25(5):429-439. PubMed ID: 37095689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
    Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial.
    Kloner RA; Neutel J; Roth EM; Weiss R; Weinberger MH; Thakker KM; Schwartz B; Shi H; Gregg AM;
    Ann Pharmacother; 2008 Nov; 42(11):1552-62. PubMed ID: 18827176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of amlodipine and losartan on blood pressure and diurnal variation in hypertensive stroke patients: a prospective, randomized, double-blind, comparative parallel study.
    Kwon HM; Shin JW; Lim JS; Hong YH; Lee YS; Nam H
    Clin Ther; 2013 Dec; 35(12):1975-82. PubMed ID: 24296324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.